Literature DB >> 2079074

Growth hormone deficiency of hypothalamic origin in septo-optic dysplasia.

S Yukizane1, Y Kimura, Y Yamashita, T Matsuishi, H Horikawa, H Ando, F Yamashita.   

Abstract

Hypothalamic pituitary function and growth hormone releasing hormone (GHRH) loading tests in two children with septo-optic dysplasia (SOD) revealed isolated GH deficiency in one and deficiencies of growth hormone, adrenocorticotropic hormone and antidiuretic hormone in the other. Secretion of GH was elicited in the first patient by single i.v. bolus administration of GHRH and after repetitive i.v. infusions of GHRH in the second. With these results we confirmed that the hypopituitarism in our patients with SOD was of hypothalamic origin. Both patients also had infantile spasms.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2079074     DOI： 10.1007/BF01959475

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  20 in total

1.  [Studies on malformation of cranio-encephalic sutures. III. Agenesis of the septum lucidum with malformation of the optic tract].

Authors:  G DE MORSIER
Journal:  Schweiz Arch Neurol Psychiatr       Date:  1956

2.  Optic hypoplasia and hypopituitarism.

Authors:  F Billson; I J Hopkins
Journal:  Lancet       Date:  1972-04-22       Impact factor: 79.321

3.  Syndrome of septo-optic-pituitary dysplasia: the clinical spectrum.

Authors:  A Morishima; G S Aranoff
Journal:  Brain Dev       Date:  1986       Impact factor: 1.961

4.  Optic nerve hypoplasia with hypopituitarism. Septo-optic dysplasia with hypopituitarism.

Authors:  H Patel; W J Tze; J U Crichton; A Q McCormick; G C Robinson; C L Dolman
Journal:  Am J Dis Child       Date:  1975-02

5.  Congenital optic nerve hypoplasia with hypothalamic-pituitary dysplasia. A review of 16 cases.

Authors:  D Margalith; W J Tze; J E Jan
Journal:  Am J Dis Child       Date:  1985-04

6.  Hypoplastic optic nerves and pituitary dysfunction. A spectrum of anatomical and endocrine abnormalities.

Authors:  R Stanhope; M A Preece; C G Brook
Journal:  Arch Dis Child       Date:  1984-02       Impact factor: 3.791

7.  The endocrine spectrum of septo-optic dysplasia.

Authors:  N Izenberg; M Rosenblum; J S Parks
Journal:  Clin Pediatr (Phila)       Date:  1984-11       Impact factor: 1.168

8.  Evidence for a hypothalamic defect in septo-optic dysplasia.

Authors:  P W Wilson; R B Easley; F F Bolander; C B Hammond
Journal:  Arch Intern Med       Date:  1978-08

9.  Optic nerve hypoplasia associated with absent septum pellucidum and hypopituitarism.

Authors:  W Krause-Brucker; D W Gardner
Journal:  Am J Ophthalmol       Date:  1980-01       Impact factor: 5.258

10.  Idiopathic growth hormone (GH) deficiency, and GH deficiency secondary to hypothalamic germinoma: effect of single and repeated administration of human GH-releasing factor (hGRF) on plasma GH level and endogenous hGRF-like immunoreactivity level in cerebrospinal fluid.

Authors:  K Chihara; Y Kashio; H Abe; N Minamitani; H Kaji; T Kita; T Fujita
Journal:  J Clin Endocrinol Metab       Date:  1985-02       Impact factor: 5.958
View more
  4 in total

Review 1.  HESX1 and Septo-Optic Dysplasia.

Authors:  Mehul Tulsidas Dattani; Iain Caf Robinson
Journal:  Rev Endocr Metab Disord       Date:  2002-12       Impact factor: 6.514

Review 2.  Prenatal corticosteroids modify glutamatergic and GABAergic synapse genomic fabric: insights from a novel animal model of infantile spasms.

Authors:  D A Iacobas; S Iacobas; T Chachua; C Goletiani; G Sidyelyeva; J Velíšková; L Velíšek
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

3.  Diabetes insipidus with impaired osmotic regulation in septo-optic dysplasia and agenesis of the corpus callosum.

Authors:  N Masera; D B Grant; R Stanhope; M A Preece
Journal:  Arch Dis Child       Date:  1994-01       Impact factor: 3.791

Review 4.  Genetics of septo-optic dysplasia.

Authors:  Daniel Kelberman; Mehul Tulsidas Dattani
Journal:  Pituitary       Date:  2007       Impact factor: 4.107
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.